RxE2 will be exhibiting at the DPHARM 2025 US Conference in Philadelphia September 16-17!
RxE2 powers community-based clinical trials through technology that expands equitable access to research. By enabling community pharmacies to operate as next-generation clinical trial sites, we recruit, engage, and retain patients where they live and receive care, integrating pharmacists into research to accelerate enrollment, improve adherence, and deliver better outcomes.
Meet us at booth #704. If you want to meet and learn more about RxE2’s technology and solutions , send us a meeting request below ⬇️.
You can also reach out to us on Linkedin to our team on site: Andy Russell.
Our accessibility and our relationship with the patients, position us best to identify potential candidates for clinical trials. It could be a life-changing drug for the patient, and you can be a part of that. – Bruno Tching, PharmD, RPh, Inland Pharmacy, CA.
